Macrophages in Intestinal Homeostasis and Inflammatory Bowel Disease

Overview

Journal Nat Rev Gastroenterol Hepatol

Specialty Gastroenterology

Date 2023 Apr 17

PMID 37069320

Authors

Lizi M Hegarty

Gareth-Rhys Jones

Calum C Bain

Affiliations

Soon will be listed here.

Abstract

Macrophages are essential for the maintenance of intestinal homeostasis, yet appear to be drivers of inflammation in the context of inflammatory bowel disease (IBD). How these peacekeepers become powerful aggressors in IBD is still unclear, but technological advances have revolutionized our understanding of many facets of their biology. In this Review, we discuss the progress made in understanding the heterogeneity of intestinal macrophages, the functions they perform in gut health and how the environment and origin can control the differentiation and longevity of these cells. We describe how these processes might change in the context of chronic inflammation and how aberrant macrophage behaviour contributes to IBD pathology, and discuss how therapeutic approaches might target dysregulated macrophages to dampen inflammation and promote mucosal healing. Finally, we set out key areas in the field of intestinal macrophage biology for which further investigation is warranted.

Citing Articles

Effects of Dietary Pretreatment with All- Lycopene on Lipopolysaccharide-Induced Jejunal Inflammation: A Multi-Pathway Phenomenon.

Mou D, Ding D, Pu J, Zhou P, Cao E, Zhang X Foods. 2025; 14(5).

PMID: 40077496 PMC: 11898642. DOI: 10.3390/foods14050794.

Immunomodulatory Potential of 6-Gingerol and 6-Shogaol in -Fermented Extract on Murine Macrophages.

Kim J, Park K, Park J, Kim B, Kim G, Hwang D Int J Mol Sci. 2025; 26(5).

PMID: 40076780 PMC: 11900057. DOI: 10.3390/ijms26052159.

Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets.

Guan F, Wang R, Yi Z, Luo P, Liu W, Xie Y Signal Transduct Target Ther. 2025; 10(1):93.

PMID: 40055311 PMC: 11889221. DOI: 10.1038/s41392-025-02124-y.

Characterization of Exosome-like Nanoparticles from Saffron Tepals and Their Immunostimulatory Activity.

Martinez Fajardo C, Lopez-Jimenez A, Lopez-Lopez S, Morote L, Moreno-Gimenez E, Diretto G Biology (Basel). 2025; 14(2).

PMID: 40001983 PMC: 11851917. DOI: 10.3390/biology14020215.

Glaucocalyxin A alleviates ulcerative colitis by inhibiting PI3K/AKT/mTOR signaling.

Zhou T, Ye Y, Chen W, Wang Y, Ding L, Liu Y Sci Rep. 2025; 15(1):6556.

PMID: 39994449 PMC: 11850606. DOI: 10.1038/s41598-025-91358-5.

References

Mowat A, Agace W . Regional specialization within the intestinal immune system. Nat Rev Immunol. 2014; 14(10):667-85. DOI: 10.1038/nri3738. View

Fiocchi C . What is "physiological" intestinal inflammation and how does it differ from "pathological" inflammation?. Inflamm Bowel Dis. 2008; 14 Suppl 2:S77-8. DOI: 10.1002/ibd.20618. View

Martin J, Chang C, Boschetti G, Ungaro R, Giri M, Grout J . Single-Cell Analysis of Crohn's Disease Lesions Identifies a Pathogenic Cellular Module Associated with Resistance to Anti-TNF Therapy. Cell. 2019; 178(6):1493-1508.e20. PMC: 7060942. DOI: 10.1016/j.cell.2019.08.008. View

Kaplan G, Windsor J . The four epidemiological stages in the global evolution of inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2020; 18(1):56-66. PMC: 7542092. DOI: 10.1038/s41575-020-00360-x. View

Ng S, Shi H, Hamidi N, Underwood F, Tang W, Benchimol E . Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017; 390(10114):2769-2778. DOI: 10.1016/S0140-6736(17)32448-0. View

Coward S, Clement F, Benchimol E, Bernstein C, Avina-Zubieta J, Bitton A . Past and Future Burden of Inflammatory Bowel Diseases Based on Modeling of Population-Based Data. Gastroenterology. 2019; 156(5):1345-1353.e4. DOI: 10.1053/j.gastro.2019.01.002. View

Jones G, Lyons M, Plevris N, Jenkinson P, Bisset C, Burgess C . IBD prevalence in Lothian, Scotland, derived by capture-recapture methodology. Gut. 2019; 68(11):1953-1960. PMC: 6839733. DOI: 10.1136/gutjnl-2019-318936. View

Mulder K, Patel A, Kong W, Piot C, Halitzki E, Dunsmore G . Cross-tissue single-cell landscape of human monocytes and macrophages in health and disease. Immunity. 2021; 54(8):1883-1900.e5. DOI: 10.1016/j.immuni.2021.07.007. View

Mills C, Kincaid K, Alt J, Heilman M, Hill A . M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol. 2000; 164(12):6166-73. DOI: 10.4049/jimmunol.164.12.6166. View

10.

Gordon S . Alternative activation of macrophages. Nat Rev Immunol. 2003; 3(1):23-35. DOI: 10.1038/nri978. View

11.

Nahrendorf M, Swirski F . Abandoning M1/M2 for a Network Model of Macrophage Function. Circ Res. 2016; 119(3):414-7. PMC: 4965179. DOI: 10.1161/CIRCRESAHA.116.309194. View

12.

Domanska D, Majid U, Karlsen V, Merok M, Beitnes A, Yaqub S . Single-cell transcriptomic analysis of human colonic macrophages reveals niche-specific subsets. J Exp Med. 2022; 219(3). PMC: 8932544. DOI: 10.1084/jem.20211846. View

13.

Tamoutounour S, Henri S, Lelouard H, de Bovis B, de Haar C, van der Woude C . CD64 distinguishes macrophages from dendritic cells in the gut and reveals the Th1-inducing role of mesenteric lymph node macrophages during colitis. Eur J Immunol. 2012; 42(12):3150-66. DOI: 10.1002/eji.201242847. View

14.

Shaw T, Houston S, Wemyss K, Bridgeman H, Barbera T, Zangerle-Murray T . Tissue-resident macrophages in the intestine are long lived and defined by Tim-4 and CD4 expression. J Exp Med. 2018; 215(6):1507-1518. PMC: 5987925. DOI: 10.1084/jem.20180019. View

15.

De Schepper S, Verheijden S, Aguilera-Lizarraga J, Viola M, Boesmans W, Stakenborg N . Self-Maintaining Gut Macrophages Are Essential for Intestinal Homeostasis. Cell. 2018; 175(2):400-415.e13. DOI: 10.1016/j.cell.2018.07.048. View

16.

Zigmond E, Varol C, Farache J, Elmaliah E, Satpathy A, Friedlander G . Ly6C hi monocytes in the inflamed colon give rise to proinflammatory effector cells and migratory antigen-presenting cells. Immunity. 2012; 37(6):1076-90. DOI: 10.1016/j.immuni.2012.08.026. View

17.

Bain C, Bravo-Blas A, Scott C, Gomez Perdiguero E, Geissmann F, Henri S . Constant replenishment from circulating monocytes maintains the macrophage pool in the intestine of adult mice. Nat Immunol. 2014; 15(10):929-937. PMC: 4169290. DOI: 10.1038/ni.2967. View

18.

Bain C, Scott C, Uronen-Hansson H, Gudjonsson S, Jansson O, Grip O . Resident and pro-inflammatory macrophages in the colon represent alternative context-dependent fates of the same Ly6Chi monocyte precursors. Mucosal Immunol. 2012; 6(3):498-510. PMC: 3629381. DOI: 10.1038/mi.2012.89. View

19.

Kamada N, Hisamatsu T, Okamoto S, Chinen H, Kobayashi T, Sato T . Unique CD14 intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFN-gamma axis. J Clin Invest. 2008; 118(6):2269-80. PMC: 2391067. DOI: 10.1172/JCI34610. View

20.

Thiesen S, Janciauskiene S, Uronen-Hansson H, Agace W, Hogerkorp C, Spee P . CD14(hi)HLA-DR(dim) macrophages, with a resemblance to classical blood monocytes, dominate inflamed mucosa in Crohn's disease. J Leukoc Biol. 2013; 95(3):531-41. DOI: 10.1189/jlb.0113021. View